Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems

被引:61
作者
Chakrabarty, Ankush [1 ]
Zavitsanou, Stamatina [1 ]
Doyle, Francis J., III [1 ]
Dassau, Eyal [1 ]
机构
[1] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA
基金
美国国家卫生研究院;
关键词
Artificial pancreas; embedded systems; event-triggering; model predictive control; type; 1; diabetes; CLOSED-LOOP CONTROL; INSULIN DELIVERY; GLUCOSE CONTROL; BLOOD-GLUCOSE; HOME-USE; MPC; SAFETY; HYPOGLYCEMIA; ADOLESCENTS; TRIALS;
D O I
10.1109/TBME.2017.2707344
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: The development of artificial pancreas (AP) technology for deployment in low-energy, embedded devices is contingent upon selecting an efficient control algorithm for regulating glucose in people with type 1 diabetes mellitus. In this paper, we aim to lower the energy consumption of the AP by reducing controller updates, that is, the number of times the decision-making algorithm is invoked to compute an appropriate insulin dose. Methods: Physiological insights into glucose management are leveraged to design an event-triggered model predictive controller (MPC) that operates efficiently, without compromising patient safety. The proposed event-triggered MPC is deployed on a wearable platform. Its robustness to latent hypoglycemia, model mismatch, and meal misinformation is tested, with and without meal announcement, on the full version of the US-FDA accepted UVA/Padovametabolic simulator. Results: The event-based controller remains on for 18 h of 41 h in closed loop with unannounced meals, while maintaining glucose in 70-180 mg/dL for 25 h, compared to 27 h for a standard MPC controller. With meal announcement, the time in 70-180 mg/dL is almost identical, with the controller operating a mere 25.88% of the time in comparison with a standard MPC. Conclusion: A novel control architecture for AP systems enables safe glycemic regulation with reduced processor computations. Significance: Our proposed framework integrated seamlessly with a wide variety of popular MPC variants reported in AP research, customizes tradeoff between glycemic regulation and efficacy according to prior design specifications, and eliminates judicious prior selection of controller sampling times.
引用
收藏
页码:575 / 586
页数:12
相关论文
共 47 条
  • [1] Andersen M, 2012, OPTIMIZATION FOR MACHINE LEARNING, P55
  • [2] [Anonymous], J DIABETES SCI TECHN
  • [3] The explicit linear quadratic regulator for constrained systems
    Bemporad, A
    Morari, M
    Dua, V
    Pistikopoulos, EN
    [J]. AUTOMATICA, 2002, 38 (01) : 3 - 20
  • [4] Energy-aware robust model predictive control based on noisy wireless sensors
    Bernardini, Daniele
    Bemporad, Alberto
    [J]. AUTOMATICA, 2012, 48 (01) : 36 - 44
  • [5] Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
    Blauw, H.
    van Bon, A. C.
    Koops, R.
    DeVries, J. H.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (07) : 671 - 677
  • [6] Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia
    Breton, Marc
    Farret, Anne
    Bruttomesso, Daniela
    Anderson, Stacey
    Magni, Lalo
    Patek, Stephen
    Man, Chiara Dalla
    Place, Jerome
    Demartini, Susan
    Del Favero, Simone
    Toffanin, Chiara
    Hughes-Karvetski, Colleen
    Dassau, Eyal
    Zisser, Howard
    Doyle, Francis J., III
    De Nicolao, Giuseppe
    Avogaro, Angelo
    Cobelli, Claudio
    Renard, Eric
    Kovatchev, Boris
    [J]. DIABETES, 2012, 61 (09) : 2230 - 2237
  • [7] Support Vector Machine Informed Explicit Nonlinear Model Predictive Control Using Low-Discrepancy Sequences
    Chakrabarty, Ankush
    Dinh, Vu
    Corless, Martin J.
    Rundell, Ann E.
    Zak, Stanislaw H.
    Buzzard, Gregery T.
    [J]. IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 2017, 62 (01) : 135 - 148
  • [8] Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial
    Dassau, Eyal
    Brown, Sue A.
    Basu, Ananda
    Pinsker, Jordan E.
    Kudva, Yogish C.
    Gondhalekar, Ravi
    Patek, Steve
    Lv, Dayu
    Schiavon, Michele
    Lee, Joon Bok
    Man, Chiara Dalla
    Hinshaw, Ling
    Castorino, Kristin
    Mallad, Ashwini
    Dadlani, Vikash
    McCrady-Spitzer, Shelly K.
    McElwee-Malloy, Molly
    Wakeman, Christian A.
    Bevier, Wendy C.
    Bradley, Paige K.
    Kovatchev, Boris
    Cobelli, Claudio
    Zisser, Howard C.
    Doyle, Francis J., III
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10) : 3878 - 3886
  • [9] Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring A safety net for the artificial pancreas
    Dassau, Eyal
    Cameron, Fraser
    Lee, Hyunjin
    Bequette, B. Wayne
    Zisser, Howard
    Jovanovic, Lois
    Chase, H. Peter
    Wilson, Darrell M.
    Buckingham, Bruce A.
    Doyle, Francis J., III
    [J]. DIABETES CARE, 2010, 33 (06) : 1249 - 1254
  • [10] In Silico Evaluation Platform for Artificial Pancreatic β-Cell Development-A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop
    Dassau, Eyal
    Palerm, Cesar C.
    Zisser, Howard
    Buckingham, Bruce A.
    Jovanovic, Lois
    Doyle, Francis J., III
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (03) : 187 - 194